Saving lives through improved use of ACTs

03 Nov 2015
The Lancet Global Health

A comment published in The Lancet Global Health, co-authored by George Jagoe

Summary

The new modelling work by Tran Dang Nguyen and colleagues in The Lancet Global Health, which focuses on optimum distribution strategies of artemisinin combination therapies (ACTs) for treatment of malaria, comes at a crucial juncture in the public health battle to contain drug resistance. At a time that many countries are heeding calls to develop aggressive national plans to eliminate malaria and are reporting encouraging news of declining morbidity and mortality, worrisome evidence in the Greater Mekong subregion of southeast Asia confirms that resistance to artemisinin and to non-artemisinin partner drugs used in ACTs remains a threat.

Read the full text on The Lancet website.